These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
178 related articles for article (PubMed ID: 12968539)
21. The first steps towards gene therapy for Parkinson's disease. Svendsen C Lancet Neurol; 2007 Sep; 6(9):754-6. PubMed ID: 17706556 [No Abstract] [Full Text] [Related]
23. Viral vectors as a tool to model and treat Parkinson's disease. Bensadoun JC; Aebischer P Wien Klin Wochenschr; 2006 Oct; 118(19-20):568-70. PubMed ID: 17136329 [No Abstract] [Full Text] [Related]
24. [Utilization of herpes simplex virus for human gene and cancer therapies]. Nishiyama Y; Kawaguchi Y Uirusu; 2003 Dec; 53(2):155-62. PubMed ID: 15071954 [No Abstract] [Full Text] [Related]
29. Targeted gene therapy for cancer: herpes simplex virus thymidine kinase gene-mediated cell killing leads to anti-tumour immunity that can be augmented by co-expression of cytokines in the tumour cells. Vile RG; Diaz RM; Castleden S; Chong H Biochem Soc Trans; 1997 May; 25(2):717-22. PubMed ID: 9191190 [No Abstract] [Full Text] [Related]
30. Helper virus-free herpes simplex virus-1 plasmid vectors for gene therapy of Parkinson's disease and other neurological disorders. Geller AI; Yu L; Wang Y; Fraefel C Exp Neurol; 1997 Mar; 144(1):98-102. PubMed ID: 9126158 [TBL] [Abstract][Full Text] [Related]
31. Gene therapy of Parkinson's disease using adeno-associated virus (AAV) vectors. Ozawa K; Fan DS; Shen Y; Muramatsu S; Fujimoto K; Ikeguchi K; Ogawa M; Urabe M; Kume A; Nakano I J Neural Transm Suppl; 2000; (58):181-91. PubMed ID: 11128607 [TBL] [Abstract][Full Text] [Related]
33. Gene Transfer of Glutamic Acid Decarboxylase 67 by Herpes Simplex Virus Vectors Suppresses Neuropathic Pain Induced by Human Immunodeficiency Virus gp120 Combined with ddC in Rats. Kanao M; Kanda H; Huang W; Liu S; Yi H; Candiotti KA; Lubarsky DA; Levitt RC; Hao S Anesth Analg; 2015 Jun; 120(6):1394-404. PubMed ID: 25851180 [TBL] [Abstract][Full Text] [Related]
34. Oncolytic herpes simplex virus for tumor therapy. Hu JC; Coffin RS Int Rev Neurobiol; 2003; 55():165-84. PubMed ID: 12968536 [No Abstract] [Full Text] [Related]
36. Gene therapy for glioblastoma [correction of gliobestome] multiform: in vivo tumor transduction with the herpes simplex thymidine kinase gene followed by ganciclovir. Stockhammer G; Brotchi J; Leblanc R; Bernstein M; Schackert G; Weber F; Ostertag C; Mulder NH; Mellstedt H; Seiler R; Yonekawa Y; Twerdy K; Kostron H; De Witte O; Lambermont M; Velu T; Laneuville P; Villemure JG; Rutka JT; Warnke P; Laseur M; Mooij JJ; Boëthius J; Mariani L; Gianella-Borradori A J Mol Med (Berl); 1997 Apr; 75(4):300-4. PubMed ID: 9151217 [No Abstract] [Full Text] [Related]
37. Viral vectors for in vivo gene transfer in Parkinson's disease: properties and clinical grade production. Mandel RJ; Burger C; Snyder RO Exp Neurol; 2008 Jan; 209(1):58-71. PubMed ID: 17916354 [TBL] [Abstract][Full Text] [Related]
38. The roles of herpes simplex virus in neuroscience. Turner SL; Jenkins FJ J Neurovirol; 1997 Apr; 3(2):110-25. PubMed ID: 9111174 [TBL] [Abstract][Full Text] [Related]
39. Herpes vector-mediated gene transfer in treatment of diseases of the nervous system. Glorioso JC; Fink DJ Annu Rev Microbiol; 2004; 58():253-71. PubMed ID: 15487938 [TBL] [Abstract][Full Text] [Related]
40. [Herpes simplex virus as a vector for gene therapy]. Miyatake S Uirusu; 1997 Dec; 47(2):239-46. PubMed ID: 9545870 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]